Clinical trial

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD

NCT00577460

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-12-01

PhasePHASE3

Study timeline

Study start (unknown)2007-12-01Date precision: month

Registry last updated2014-05-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

PramipexoleDRUG · verified · RxNorm: pramipexole

PlaceboDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

SeoulSouth Korea5 MoscowRussia5 BarcelonaSpain2 RomaItaly2 BratislavaSlovakia2 MadridSpain1 WarsawPoland1 Saint PetersburgRussia1 PragueCzechia1 KrakowPoland1 StockholmSweden1 GdanskPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00577460 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.